Elevated transforming growth factor (TGF)-β1 and thrombospondin (TSP)-1 levels in bronchoalveolar lavage (BAL) fluid of patients with pulmonary fibrosis

M. Ohmori, M. Kataoka, H. Ichikawa, W. Ito, Y. Tanimoto, A. Kanehiro, M. Tanimoto (Okayama City, Japan)

Source: Annual Congress 2003 - Markers, mediators and mechanisms of human lung injury
Session: Markers, mediators and mechanisms of human lung injury
Session type: Thematic Poster Session
Number: 612
Disease area: Interstitial lung diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. Ohmori, M. Kataoka, H. Ichikawa, W. Ito, Y. Tanimoto, A. Kanehiro, M. Tanimoto (Okayama City, Japan). Elevated transforming growth factor (TGF)-β1 and thrombospondin (TSP)-1 levels in bronchoalveolar lavage (BAL) fluid of patients with pulmonary fibrosis. Eur Respir J 2003; 22: Suppl. 45, 612

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Elevated TGF- b1 concentration in bronchoalveolar lavage fluid from patients with primary lung cancer
Source: Eur Respir J 2002; 20: Suppl. 38, 585s
Year: 2002

Elevated NT-3 levels in bronchoalveolar lavage fluid of patients with pulmonary sarcoidosis
Source: Eur Respir J 2007; 30: Suppl. 51, 586s
Year: 2007

Levels of tumour necrosis factor and interferon in bronchoalveolar lavage fluid and blood serum in children with chronic bronchiolitis
Source: Eur Respir J 2001; 18: Suppl. 33, 530s
Year: 2001

Transforming growth factor beta in serum and bronchoalveolar lavage of COPD patients
Source: Annual Congress 2007 - Molecular pathogenesis: focus on COPD and asthma
Year: 2007


Angiogenetic profiles (VEGF and VEGF receptor-1, Flt-1) in bronchoalveolar lavage fluid in patients with interstitial lung diseases
Source: Annual Congress 2008 - Role of bronchoalveolar lavage in studying the pathophysiology of interstitial lung disease
Year: 2008

Soluble Fas-ligand levels in bronchoalveolar lavage fluid before and after interferon-γ-1b treatment in idiopathic pulmonary fibrosis
Source: Eur Respir J 2005; 26: Suppl. 49, 334s
Year: 2005

Studies on hepatocyte growth factor (HGF) in bronchoalveolar lavage (BAL) do not support the concept on its antifibrotic properties in idiopathic pulmonary fibrosis (IPF)
Source: International Congress 2015 – Interstitial lung diseases II
Year: 2015

Measurement of trefoil factor peptides in bronchioalveolar lavage (BAL) fluids from patients with COPD or pulmonary cancer
Source: Annual Congress 2009 - COPD: basic science and clinical studies
Year: 2009

CCR5 expression and CC-chemokine levels in broncho-alveolar lavage (BAL) fluid of patients with idiopathic pulmonary fibrosis (IPF)
Source: Eur Respir J 2002; 20: Suppl. 38, 598s
Year: 2002

Elevated level of tissue inhibitor of metalloproteinase 1 in bronchoalveolar lavage fluid in fibrosing lung diseases
Source: Eur Respir J 2002; 20: Suppl. 38, 313s
Year: 2002

CCL20 level in bronchoalveolar lavage fluid is correlated with the levels of serum indications in patients with pulmonary sarcoidosis
Source: Annual Congress 2010 - Usefulness of bronchoalveolar lavage in diffuse parenchymal lung disease
Year: 2010


Overexpression of matrix metalloproteinase-7 (MMP-7) in bronchoalveolar lavage fluid (BALF) of IPF and lung cancer patients
Source: Annual Congress 2011 - Bronchoalveolar lavage and biomarkers in diffuse parenchymal lung disease
Year: 2011


Insulin-like growth factor-1 in idiopathic pulmonary fibrosis bronchoalveolar lavage fluid protects lung fibroblasts from apoptosis
Source: Eur Respir J 2001; 18: Suppl. 33, 358s
Year: 2001

Increased Clara cell protein 16 levels in the bronchoalveolar lavage fluid of idiopathic pulmonary fibrosis patients
Source: Annual Congress 2008 - Role of bronchoalveolar lavage in studying the pathophysiology of interstitial lung disease
Year: 2008

Induced sputum versus bronchoalveolar lavage fluid (BALF) in patients with idiopathic pulmonary fibrosis (IPF)
Source: Eur Respir J 2003; 22: Suppl. 45, 227s
Year: 2003

Epidermal growth factor in paediatric bronchoalveolar lavage fluid
Source: Eur Respir J 2004; 24: Suppl. 48, 271s
Year: 2004

Evaluation in bronchoalveolar lavage fluid (BALF) of cytokines TNF-alpha, IL-6 and IL-8 in children with severe bronchial asthma (BA)
Source: Annual Congress 2010 - Phenotypes, mechanisms and diagnosis of asthma in childhood
Year: 2010

An indicative role of serum transforming growth factor-beta 1 (TGF-β1) level on the determination of clinical severity of pulmonary tuberculosis
Source: Annual Congress 2005 - Diagnosis of tuberculosis and LTBI
Year: 2005


Fibrocytes are detected in bronchoalveolar lavage (BAL) fluid in idiopathic pulmonary fibrosis (IPF)
Source: Annual Congress 2011 - Bronchoalveolar lavage and biomarkers in diffuse parenchymal lung disease
Year: 2011


Lymphocyte and macrophage apoptosis in bronchoalveolar lavage fluid (BALF) of COPD patients
Source: Eur Respir J 2006; 28: Suppl. 50, 749s
Year: 2006